Reset filters
  • 25 September 2007

PrEP could prevent up to three million HIV infections in ten years in Africa

Read the article
  • 21 September 2007

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

Read the article
  • 21 September 2007

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir

Read the article
  • 20 September 2007

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV

Read the article
  • 20 September 2007

ICAAC: Dapivirine safe and tolerable as potential vaginal microbicide; displays potential in combination with other agents

Read the article
  • 20 September 2007

ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced

Read the article
  • 19 September 2007

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

Read the article
  • 19 September 2007

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

Read the article
  • 19 September 2007

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.